Table I.
Group | Mean age, yrs (sd) | Female, n (%) | Male, n (%) | Total, n |
---|---|---|---|---|
Non-fracture control | 78.8 (4.0) | 4 (66.7) | 2 (33.3) | 6 |
Fracture control | 82.9 (7.8) | 8 (57.1) | 6 (42.9) | 14 |
Bisphosphonate therapy | 77.3 (8.0) | 7 (70.0) | 3 (30.0) | 10 |
Group | Mean age, yrs (sd) | Female, n (%) | Male, n (%) | Total, n |
---|---|---|---|---|
Non-fracture control | 78.8 (4.0) | 4 (66.7) | 2 (33.3) | 6 |
Fracture control | 82.9 (7.8) | 8 (57.1) | 6 (42.9) | 14 |
Bisphosphonate therapy | 77.3 (8.0) | 7 (70.0) | 3 (30.0) | 10 |